212 related articles for article (PubMed ID: 31553471)
41. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
42. A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.
Tameris M; Hokey DA; Nduba V; Sacarlal J; Laher F; Kiringa G; Gondo K; Lazarus EM; Gray GE; Nachman S; Mahomed H; Downing K; Abel B; Scriba TJ; McClain JB; Pau MG; Hendriks J; Dheenadhayalan V; Ishmukhamedov S; Luabeya AK; Geldenhuys H; Shepherd B; Blatner G; Cardenas V; Walker R; Hanekom WA; Sadoff J; Douoguih M; Barker L; Hatherill M
Vaccine; 2015 Jun; 33(25):2944-54. PubMed ID: 25936724
[TBL] [Abstract][Full Text] [Related]
43. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.
Padungchan S; Konjanart S; Kasiratta S; Daramas S; ten Dam HG
Bull World Health Organ; 1986; 64(2):247-58. PubMed ID: 3488839
[TBL] [Abstract][Full Text] [Related]
44. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV;
Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662
[TBL] [Abstract][Full Text] [Related]
45. Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses.
Barreto ML; Pilger D; Pereira SM; Genser B; Cruz AA; Cunha SS; Sant'Anna C; Hijjar MA; Ichihara MY; Rodrigues LC
Vaccine; 2014 Jun; 32(30):3759-64. PubMed ID: 24852722
[TBL] [Abstract][Full Text] [Related]
46. [Tuberculosis in Iceland. 1976].
Sigurdsson S
Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
[TBL] [Abstract][Full Text] [Related]
47. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
Fowler VG; Allen KB; Moreira ED; Moustafa M; Isgro F; Boucher HW; Corey GR; Carmeli Y; Betts R; Hartzel JS; Chan IS; McNeely TB; Kartsonis NA; Guris D; Onorato MT; Smugar SS; DiNubile MJ; Sobanjo-ter Meulen A
JAMA; 2013 Apr; 309(13):1368-78. PubMed ID: 23549582
[TBL] [Abstract][Full Text] [Related]
48. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.
Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
Lancet Infect Dis; 2016 Feb; 16(2):219-26. PubMed ID: 26603173
[TBL] [Abstract][Full Text] [Related]
49. Childhood cancer among Alaska Natives.
Lanier AP; Holck P; Ehrsam Day G; Key C
Pediatrics; 2003 Nov; 112(5):e396. PubMed ID: 14595083
[TBL] [Abstract][Full Text] [Related]
50. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
51. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
[TBL] [Abstract][Full Text] [Related]
52. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
[TBL] [Abstract][Full Text] [Related]
53. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
[TBL] [Abstract][Full Text] [Related]
54. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
Narayanan PR
Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.
Hawkridge A; Hatherill M; Little F; Goetz MA; Barker L; Mahomed H; Sadoff J; Hanekom W; Geiter L; Hussey G;
BMJ; 2008 Nov; 337():a2052. PubMed ID: 19008268
[TBL] [Abstract][Full Text] [Related]
56. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
57. BCG and vole bacillus vaccination in adolescence and mortality from leukaemia.
Sutherland I
Stat Med; 1982; 1(4):329-35. PubMed ID: 6764827
[TBL] [Abstract][Full Text] [Related]
58. Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar.
Berendsen MLT; Øland CB; Bles P; Jensen AKG; Kofoed PE; Whittle H; de Bree LCJ; Netea MG; Martins C; Benn CS; Aaby P
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):166-172. PubMed ID: 30715451
[TBL] [Abstract][Full Text] [Related]
59. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
[TBL] [Abstract][Full Text] [Related]
60. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
